197 related articles for article (PubMed ID: 17117426)
21. In Vitro Assessment of Uptake and Lysosomal Sequestration of Respiratory Drugs in Alveolar Macrophage Cell Line NR8383.
Ufuk A; Somers G; Houston JB; Galetin A
Pharm Res; 2015 Dec; 32(12):3937-51. PubMed ID: 26224396
[TBL] [Abstract][Full Text] [Related]
22. A chemical strategy to manipulate the intracellular localization of drugs in resistant cancer cells.
Duvvuri M; Konkar S; Funk RS; Krise JM; Krise JP
Biochemistry; 2005 Dec; 44(48):15743-9. PubMed ID: 16313177
[TBL] [Abstract][Full Text] [Related]
23. Lysosome membrane permeability to amines.
Andrew CL; Klemm AR; Lloyd JB
Biochim Biophys Acta; 1997 Nov; 1330(1):71-82. PubMed ID: 9375814
[TBL] [Abstract][Full Text] [Related]
24. Sequestration of organic cations by acidified hepatic endocytic vesicles and implications for biliary excretion.
Van Dyke RW; Faber ED; Meijer DK
J Pharmacol Exp Ther; 1992 Apr; 261(1):1-11. PubMed ID: 1348536
[TBL] [Abstract][Full Text] [Related]
25. Lysosomes contribute to anomalous pharmacokinetic behavior of melanocortin-4 receptor agonists.
Gong Y; Zhao Z; McConn DJ; Beaudet B; Tallman M; Speake JD; Ignar DM; Krise JP
Pharm Res; 2007 Jun; 24(6):1138-44. PubMed ID: 17373577
[TBL] [Abstract][Full Text] [Related]
26. Quantitation of the lysosomotropic character of cationic amphiphilic drugs using the fluorescent basic amine Red DND-99.
Lemieux B; Percival MD; Falgueyret JP
Anal Biochem; 2004 Apr; 327(2):247-51. PubMed ID: 15051542
[TBL] [Abstract][Full Text] [Related]
27. Influence of lysosomal sequestration on multidrug resistance in cancer cells.
Halaby R
Cancer Drug Resist; 2019; 2(1):31-42. PubMed ID: 35582144
[TBL] [Abstract][Full Text] [Related]
28. Utilising Magnetically Isolated Lysosomes for Direct Quantification of Intralysosomal Drug Concentrations by LC-MS/MS Analysis: An Investigatory Study With Imipramine.
Francis L; Harrell A; Hallifax D; Galetin A
J Pharm Sci; 2020 Sep; 109(9):2891-2901. PubMed ID: 32504630
[TBL] [Abstract][Full Text] [Related]
29. Recent approaches to intracellular delivery of drugs and DNA and organelle targeting.
Torchilin VP
Annu Rev Biomed Eng; 2006; 8():343-75. PubMed ID: 16834560
[TBL] [Abstract][Full Text] [Related]
30. A review of drug-induced lysosomal disorders of the liver in man and laboratory animals.
Schneider P; Korolenko TA; Busch U
Microsc Res Tech; 1997 Feb; 36(4):253-75. PubMed ID: 9140926
[TBL] [Abstract][Full Text] [Related]
31. Monitoring lysosomal activity in nanoparticle-treated cells.
Neun BW; Stern ST
Methods Mol Biol; 2011; 697():207-12. PubMed ID: 21116970
[TBL] [Abstract][Full Text] [Related]
32. Lipophilic cationic drugs increase the permeability of lysosomal membranes in a cell culture system.
Kornhuber J; Henkel AW; Groemer TW; Städtler S; Welzel O; Tripal P; Rotter A; Bleich S; Trapp S
J Cell Physiol; 2010 Jul; 224(1):152-64. PubMed ID: 20301195
[TBL] [Abstract][Full Text] [Related]
33. Intracellular protein degradation: from a vague idea through the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting.
Ciechanover A
Bioorg Med Chem; 2013 Jun; 21(12):3400-10. PubMed ID: 23485445
[TBL] [Abstract][Full Text] [Related]
34. Amine oxidases and monooxygenases in the in vivo metabolism of xenobiotic amines in humans: has the involvement of amine oxidases been neglected?
Strolin Benedetti M; Tipton KF; Whomsley R
Fundam Clin Pharmacol; 2007 Oct; 21(5):467-80. PubMed ID: 17868200
[TBL] [Abstract][Full Text] [Related]
35. Lysosomotropic compounds and spermine enzymatic oxidation products in cancer therapy (review).
Agostinelli E; Seiler N
Int J Oncol; 2007 Sep; 31(3):473-84. PubMed ID: 17671672
[TBL] [Abstract][Full Text] [Related]
36. Assessment of cation trapping by cellular acidic compartments.
Marceau F; Roy C; Bouthillier J
Methods Enzymol; 2014; 534():119-31. PubMed ID: 24359951
[TBL] [Abstract][Full Text] [Related]
37. Peptide-mediated cell penetration and targeted delivery of gold nanoparticles into lysosomes.
Dekiwadia CD; Lawrie AC; Fecondo JV
J Pept Sci; 2012 Aug; 18(8):527-34. PubMed ID: 22764089
[TBL] [Abstract][Full Text] [Related]
38. The lysosome: from waste bag to potential therapeutic target.
Appelqvist H; Wäster P; Kågedal K; Öllinger K
J Mol Cell Biol; 2013 Aug; 5(4):214-26. PubMed ID: 23918283
[TBL] [Abstract][Full Text] [Related]
39. Intracellular protein degradation: from a vague idea through the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting.
Ciechanover A
Medicina (B Aires); 2010; 70(2):105-19. PubMed ID: 20447892
[TBL] [Abstract][Full Text] [Related]
40. A shortcut to the lysosome: the mannose-6-phosphate-independent pathway.
Coutinho MF; Prata MJ; Alves S
Mol Genet Metab; 2012 Nov; 107(3):257-66. PubMed ID: 22884962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
